STLN · ISSUER CIK 1799191
Starling Oncology, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Starling Oncology, Inc. insiders reported $78K of open-market purchases and $1.9M of sales on SEC Form 4. The largest buyer was Chernett Jorey (10% Owner), with $78K.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$78KInsider buying
$1.9MInsider selling
−$1.9MNet open-market
Aug 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 202617:11 | Aug 21, 2026 | STLN | Director | S · Sell10b5-1 | $6.51 | −298,853 | 411,976 | -42% | −$1.9M | ||
| Aug 17, 202610:13 | Aug 14, 2026 | STLN | 10% Owner | P · Buy | $6.54 | +12,000 | 10,660,858 | +0% | +$78K | +2.0% | +1.7% |